Wockhardt Q1 Results
- BSE: 532300
- NSE: WOCKPHARMA
- ISIN: INE049B01025
- Sector: Biotechnology & Drugs
BSE
1,335
-56.00 (-4.03%)
-56.00 (-4.03%)Volume8.89 K
Updated: Tue 21 Jan, 2025 | 11:16:24
NSE
1,337-55.50 (-3.99%)
-55.50 (-3.99%)Volume85.75 K
Updated: Tue 21 Jan, 2025 | 11:01:55
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Wockhardt Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 24 | Mar 24 | QoQ Comp | Jun 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 739.00 | 700.00 | 5.57% | 644.00 | 14.75% |
| Selling/ General/ Admin Expenses Total | 160.00 | 157.00 | 1.91% | 154.00 | 3.90% |
| Depreciation/ Amortization | 54.00 | 58.00 | -6.90% | 55.00 | -1.82% |
| Other Operating Expenses Total | 174.00 | 219.00 | -20.55% | 190.00 | -8.42% |
| Total Operating Expense | 701.00 | 807.00 | -13.14% | 695.00 | 0.86% |
| Operating Income | 38.00 | -107.00 | 0.00% | -51.00 | 0.00% |
| Net Income Before Taxes | -6.00 | -180.00 | -96.67% | -118.00 | -94.92% |
| Net Income | -14.00 | -169.00 | -91.72% | -134.00 | -89.55% |
| Diluted Normalized EPS | -0.95 | -5.80 | -83.61% | -8.65 | -89.02% |